Please provide your email address to receive an email when new articles are posted on . WAIKOLOA, Hawaii — Recurrent retinal detachment with proliferative vitreoretinopathy can be effectively managed ...
Please provide your email address to receive an email when new articles are posted on . Patients with epiretinal membrane after proliferative vitreoretinopathy repair may benefit from early peeling, ...
To report the incidence rate, management, and surgical outcomes of rhegmatogenous retinal detachment (RRD) in children who underwent pars plana vitrectomy (PPV) with sutured scleral-fixated ...
To evaluate the role of bevacizumab injected into the silicone oil at the end of retinal reattachment surgery for rhegmatogenous retinal detachment (RRD) associated with severe proliferative ...
Reports for the use of steroids in the management of proliferative vitreoretinopathy (PVR) are inconsistent. The advent of a sustained-release implant that can release dexamethasone for 3-4 months in ...
Age, disease and even playing certain sports like basketball can increase a person’s risk of developing a detached retina. While surgery is typically used to treat the condition, subsequent scarring ...
SINGAPORE – Singapore scientists have developed a bio-functional thermogel, a type of synthetic polymer, to prevent retinal scarring caused by failed retinal detachment repair surgery. Proliferative ...
BOSTON – New research from Boston Medical Center found that Black and Hispanics patients treated with surgery for retinal detachment had worse vision results than white patients. Published in the ...
Int Ophthalmol Clin. 2013;53(4):127-137. The second window is from 7 to 14 days. "Once the inflammation is controlled or the originally lacerated vessels have healed, or both, a second window appears ...
At the back of the retina in adult vertebrate eyes is a highly differentiated layer of cells known as the retinal pigment epithelium (RPE). These cells do not normally multiply or migrate in adults, ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that ADX-2191 has been designated an orphan medicinal product by the European Commission for the ...
Researchers at the U.S. Army Institute of Surgical Research are looking for a novel way to treat eye injuries that can result in blindness. According to USAISR researchers, a non-invasive treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback